Soares, Paula I. P., Coro Echeverria, Ana Catarina Baptista, Carlos João, Susete Fernandes, Ana Almeida, Jorge Carvalho Silva, Maria Helena Godinho, and João Paulo Borges. "
Hybrid polysaccharide-based systems for biomedical applications." In
Hybrid Polymer Composite Materials: Applications, edited by Manju Kumari Thakur, Vijay Kumar Thakur and Asokan Pappu, 107-149. USA: Woodhead Publishing, Elsevier, 2017.
AbstractHybrid materials have been widely studied for structural applications. Polysaccharide-based fibers, especially cellulosic fibers, have been explored in the last two decades as substitutes of the traditional reinforcements made of glass or carbon fibers due to their mechanical properties. However, their biocompatibility, biodegradability, and chemistry have attracted the researchers and new developments in the field of smart and functional materials arise in diverse applications. This chapter will focus on the biomedical applications of polysaccharide-based smart and functional materials, namely those concerning biosensors and actuators, theranostic systems, and tissue-engineering applications. Special attention will be given to cellulose- and chitin/chitosan-based hybrid materials because these are the two most abundant polysaccharides and probably the most promising for the development of hybrid materials for biomedical applications. Biomimetic strategies for the development of smart and functional hybrid materials will also be highlighted.
Soares, Paula I. P., Isabel Ferreira, and João Paulo Borges. "
Application of Hyperthermia for Cancer Treatment: Recent Patents Review." In
Topics in Anti-Cancer Research, Vol. 3, edited by Atta-ur-Rahman and Khurshid Zaman, 342-383. Bentham Science Publishers, 2014.
AbstractCancer is one of the main causes of death in the world and its incidence increases every day. Current treatments are insufficient and present many breaches. Hyperthermia is an old concept and was early established as a cancer treatment option, mainly in superficial cancers. More recently, the concept of intracellular hyperthermia emerged wherein magnetic particles are concentrated at the tumor site and remotely heated using an applied magnetic field to achieve hyperthermic temperatures (42-45ºC). Many patents have been registered in this area since the year 2000. This chapter presents the most relevant information organized in two main categories according to the use or not of nanotechnology. The patents without nanotechnology were divided into the following subcategories: 1) external Radio-Frequency devices; 2) hyperthermic perfusion; 3) frequency enhancers; 4) applying heat to the target site using a catheter; and 5) injection of magnetic and ferroelectric particles. The patents with nanotechnology were divided into three subcategories: 1) hyperthermia devices; 2) nanoparticles; and 3) nanostructures. The use of magnetic nanoparticles is a very promising treatment approach since it may be used for diagnostic and treatment. Magnetic nanoparticle could be applied to detect and diagnose the tumor and to carry a pharmacological active drug to be delivered in the tumor site or apply hyperthermia through an external magnetic field.